世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および米国のAtezolizumab市場の洞察、2027年までの予測

世界および米国のAtezolizumab市場の洞察、2027年までの予測


Global and United States Atezolizumab Market Insights, Forecast to 2027

市場分析とインサイト世界と米国のAtezolizumab市場 当レポートでは、世界および米国のAtezolizumab市場に焦点を当てています。 2020年のAtezolizumabの世界市場規模はXX百万米ドルで、2021年から2027年の間にX... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ
2021年11月5日 US$3,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

市場分析とインサイト世界と米国のAtezolizumab市場
当レポートでは、世界および米国のAtezolizumab市場に焦点を当てています。
2020年のAtezolizumabの世界市場規模はXX百万米ドルで、2021年から2027年の間にXX%のCAGRで、2027年末までにXX百万米ドルに達すると予想されています。米国では、Atezolizumabの市場規模は2020年のXX百万米ドルから2027年にはXX百万米ドルになり、予測期間中にXX%のCAGRで成長すると予測されています。

世界のAtezolizumabの範囲と市場規模
Atezolizumabの市場は、地域(国)別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のAtezolizumab市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年までの地域(国)別、タイプ別、アプリケーション別の収益と予測に焦点を当てています。
米国市場では、2016-2027年のAtezolizumabの市場規模を、プレイヤー別、タイプ別、アプリケーション別に取り上げています。主要なプレイヤーには、アメリカ合衆国で重要な役割を果たす世界的なプレイヤーと地域のプレイヤーが含まれます。

タイプ別セグメント
用途:単剤
用途:単剤化学療法併用

用途別セグメント
膀胱がん
肺がん
進行性トリプルネガティブ乳がん
頭頸部がん
尿路上皮癌
腎細胞癌
肝細胞癌(HCC)
その他

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

会社別
ジェネンテック(ロシュ)


ページTOPに戻る


目次

1 Study Coverage
1.1 Atezolizumab Product Introduction
1.2 Market by Type
1.2.1 Global Atezolizumab Market Size Growth Rate by Type
1.2.2 Use: Single Drug
1.2.3 Use: Chemotherapy Combination
1.3 Market by Application
1.3.1 Global Atezolizumab Market Size Growth Rate by Application
1.3.2 Bladder Cancer
1.3.3 Lung Cancer
1.3.4 Advanced Triple-negative Breast Cancer
1.3.5 Head and Neck Cancer
1.3.6 Urothelial Carcinoma
1.3.7 Renal Cell Carcinoma
1.3.8 Hepatocellular Carcinoma (HCC)
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Atezolizumab Market Size, Estimates and Forecasts
2.1.1 Global Atezolizumab Revenue 2016-2027
2.1.2 Global Atezolizumab Sales 2016-2027
2.2 Global Atezolizumab, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Atezolizumab Historical Market Size by Region (2016-2021)
2.3.1 Global Atezolizumab Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Atezolizumab Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Atezolizumab Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Atezolizumab Sales Forecast by Region (2022-2027)
2.4.2 Global Atezolizumab Revenue Forecast by Region (2022-2027)

3 Global Atezolizumab Competitor Landscape by Players
3.1 Global Top Atezolizumab Manufacturers by Sales
3.1.1 Global Atezolizumab Sales by Manufacturer (2016-2021)
3.1.2 Global Atezolizumab Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Atezolizumab Manufacturers by Revenue
3.2.1 Key Atezolizumab Manufacturers Covered: Ranking by Revenue
3.2.2 Global Atezolizumab Revenue by Manufacturers (2016-2021)
3.2.3 Global Atezolizumab Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Atezolizumab Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Atezolizumab Revenue in 2020
3.2.6 Global Atezolizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Atezolizumab Price by Manufacturers
3.4 Global Atezolizumab Manufacturing Base Distribution, Product Types
3.4.1 Atezolizumab Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Atezolizumab Product Type
3.4.3 Date of International Manufacturers Enter into Atezolizumab Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Atezolizumab Market Size by Type (2016-2021)
4.1.1 Global Atezolizumab Sales by Type (2016-2021)
4.1.2 Global Atezolizumab Revenue by Type (2016-2021)
4.1.3 Atezolizumab Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Atezolizumab Market Size Forecast by Type (2022-2027)
4.2.1 Global Atezolizumab Sales Forecast by Type (2022-2027)
4.2.2 Global Atezolizumab Revenue Forecast by Type (2022-2027)
4.2.3 Atezolizumab Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Atezolizumab Market Size by Application (2016-2021)
5.1.1 Global Atezolizumab Sales by Application (2016-2021)
5.1.2 Global Atezolizumab Revenue by Application (2016-2021)
5.1.3 Atezolizumab Price by Application (2016-2021)
5.2 Atezolizumab Market Size Forecast by Application (2022-2027)
5.2.1 Global Atezolizumab Sales Forecast by Application (2022-2027)
5.2.2 Global Atezolizumab Revenue Forecast by Application (2022-2027)
5.2.3 Global Atezolizumab Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
6.1 United States Atezolizumab Market Size YoY Growth 2016-2027
6.1.1 United States Atezolizumab Sales YoY Growth 2016-2027
6.1.2 United States Atezolizumab Revenue YoY Growth 2016-2027
6.1.3 United States Atezolizumab Market Share in Global Market 2016-2027
6.2 United States Atezolizumab Market Size by Players (International and Local Players)
6.2.1 United States Top Atezolizumab Players by Sales (2016-2021)
6.2.2 United States Top Atezolizumab Players by Revenue (2016-2021)
6.3 United States Atezolizumab Historic Market Review by Type (2016-2021)
6.3.1 United States Atezolizumab Sales Market Share by Type (2016-2021)
6.3.2 United States Atezolizumab Revenue Market Share by Type (2016-2021)
6.3.3 United States Atezolizumab Price by Type (2016-2021)
6.4 United States Atezolizumab Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Atezolizumab Sales Forecast by Type (2022-2027)
6.4.2 United States Atezolizumab Revenue Forecast by Type (2022-2027)
6.4.3 United States Atezolizumab Price Forecast by Type (2022-2027)
6.5 United States Atezolizumab Historic Market Review by Application (2016-2021)
6.5.1 United States Atezolizumab Sales Market Share by Application (2016-2021)
6.5.2 United States Atezolizumab Revenue Market Share by Application (2016-2021)
6.5.3 United States Atezolizumab Price by Application (2016-2021)
6.6 United States Atezolizumab Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Atezolizumab Sales Forecast by Application (2022-2027)
6.6.2 United States Atezolizumab Revenue Forecast by Application (2022-2027)
6.6.3 United States Atezolizumab Price Forecast by Application (2022-2027)

7 North America
7.1 North America Atezolizumab Market Size YoY Growth 2016-2027
7.2 North America Atezolizumab Market Facts & Figures by Country
7.2.1 North America Atezolizumab Sales by Country (2016-2021)
7.2.2 North America Atezolizumab Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Atezolizumab Market Size YoY Growth 2016-2027
8.2 Asia Pacific Atezolizumab Market Facts & Figures by Region
8.2.1 Asia Pacific Atezolizumab Sales by Region (2016-2021)
8.2.2 Asia Pacific Atezolizumab Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Atezolizumab Market Size YoY Growth 2016-2027
9.2 Europe Atezolizumab Market Facts & Figures by Country
9.2.1 Europe Atezolizumab Sales by Country (2016-2021)
9.2.2 Europe Atezolizumab Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Atezolizumab Market Size YoY Growth 2016-2027
10.2 Latin America Atezolizumab Market Facts & Figures by Country
10.2.1 Latin America Atezolizumab Sales by Country (2016-2021)
10.2.2 Latin America Atezolizumab Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Atezolizumab Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Atezolizumab Market Facts & Figures by Country
11.2.1 Middle East and Africa Atezolizumab Sales by Country (2016-2021)
11.2.2 Middle East and Africa Atezolizumab Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Genentech (Roche)
12.1.1 Genentech (Roche) Corporation Information
12.1.2 Genentech (Roche) Description and Business Overview
12.1.3 Genentech (Roche) Atezolizumab Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Genentech (Roche) Atezolizumab Products Offered
12.1.5 Genentech (Roche) Recent Development
12.11 Genentech (Roche)
12.11.1 Genentech (Roche) Corporation Information
12.11.2 Genentech (Roche) Description and Business Overview
12.11.3 Genentech (Roche) Atezolizumab Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Genentech (Roche) Atezolizumab Products Offered
12.11.5 Genentech (Roche) Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Atezolizumab Industry Trends
13.2 Atezolizumab Market Drivers
13.3 Atezolizumab Market Challenges
13.4 Atezolizumab Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Atezolizumab Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る


 

Summary

Market Analysis and Insights: Global and United States Atezolizumab Market
This report focuses on global and United States Atezolizumab market.
In 2020, the global Atezolizumab market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In United States the Atezolizumab market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Atezolizumab Scope and Market Size
Atezolizumab market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Atezolizumab market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Atezolizumab market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
Use: Single Drug
Use: Chemotherapy Combination

Segment by Application
Bladder Cancer
Lung Cancer
Advanced Triple-negative Breast Cancer
Head and Neck Cancer
Urothelial Carcinoma
Renal Cell Carcinoma
Hepatocellular Carcinoma (HCC)
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Genentech (Roche)



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Atezolizumab Product Introduction
1.2 Market by Type
1.2.1 Global Atezolizumab Market Size Growth Rate by Type
1.2.2 Use: Single Drug
1.2.3 Use: Chemotherapy Combination
1.3 Market by Application
1.3.1 Global Atezolizumab Market Size Growth Rate by Application
1.3.2 Bladder Cancer
1.3.3 Lung Cancer
1.3.4 Advanced Triple-negative Breast Cancer
1.3.5 Head and Neck Cancer
1.3.6 Urothelial Carcinoma
1.3.7 Renal Cell Carcinoma
1.3.8 Hepatocellular Carcinoma (HCC)
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Atezolizumab Market Size, Estimates and Forecasts
2.1.1 Global Atezolizumab Revenue 2016-2027
2.1.2 Global Atezolizumab Sales 2016-2027
2.2 Global Atezolizumab, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Atezolizumab Historical Market Size by Region (2016-2021)
2.3.1 Global Atezolizumab Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Atezolizumab Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Atezolizumab Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Atezolizumab Sales Forecast by Region (2022-2027)
2.4.2 Global Atezolizumab Revenue Forecast by Region (2022-2027)

3 Global Atezolizumab Competitor Landscape by Players
3.1 Global Top Atezolizumab Manufacturers by Sales
3.1.1 Global Atezolizumab Sales by Manufacturer (2016-2021)
3.1.2 Global Atezolizumab Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Atezolizumab Manufacturers by Revenue
3.2.1 Key Atezolizumab Manufacturers Covered: Ranking by Revenue
3.2.2 Global Atezolizumab Revenue by Manufacturers (2016-2021)
3.2.3 Global Atezolizumab Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Atezolizumab Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Atezolizumab Revenue in 2020
3.2.6 Global Atezolizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Atezolizumab Price by Manufacturers
3.4 Global Atezolizumab Manufacturing Base Distribution, Product Types
3.4.1 Atezolizumab Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Atezolizumab Product Type
3.4.3 Date of International Manufacturers Enter into Atezolizumab Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Atezolizumab Market Size by Type (2016-2021)
4.1.1 Global Atezolizumab Sales by Type (2016-2021)
4.1.2 Global Atezolizumab Revenue by Type (2016-2021)
4.1.3 Atezolizumab Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Atezolizumab Market Size Forecast by Type (2022-2027)
4.2.1 Global Atezolizumab Sales Forecast by Type (2022-2027)
4.2.2 Global Atezolizumab Revenue Forecast by Type (2022-2027)
4.2.3 Atezolizumab Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Atezolizumab Market Size by Application (2016-2021)
5.1.1 Global Atezolizumab Sales by Application (2016-2021)
5.1.2 Global Atezolizumab Revenue by Application (2016-2021)
5.1.3 Atezolizumab Price by Application (2016-2021)
5.2 Atezolizumab Market Size Forecast by Application (2022-2027)
5.2.1 Global Atezolizumab Sales Forecast by Application (2022-2027)
5.2.2 Global Atezolizumab Revenue Forecast by Application (2022-2027)
5.2.3 Global Atezolizumab Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
6.1 United States Atezolizumab Market Size YoY Growth 2016-2027
6.1.1 United States Atezolizumab Sales YoY Growth 2016-2027
6.1.2 United States Atezolizumab Revenue YoY Growth 2016-2027
6.1.3 United States Atezolizumab Market Share in Global Market 2016-2027
6.2 United States Atezolizumab Market Size by Players (International and Local Players)
6.2.1 United States Top Atezolizumab Players by Sales (2016-2021)
6.2.2 United States Top Atezolizumab Players by Revenue (2016-2021)
6.3 United States Atezolizumab Historic Market Review by Type (2016-2021)
6.3.1 United States Atezolizumab Sales Market Share by Type (2016-2021)
6.3.2 United States Atezolizumab Revenue Market Share by Type (2016-2021)
6.3.3 United States Atezolizumab Price by Type (2016-2021)
6.4 United States Atezolizumab Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Atezolizumab Sales Forecast by Type (2022-2027)
6.4.2 United States Atezolizumab Revenue Forecast by Type (2022-2027)
6.4.3 United States Atezolizumab Price Forecast by Type (2022-2027)
6.5 United States Atezolizumab Historic Market Review by Application (2016-2021)
6.5.1 United States Atezolizumab Sales Market Share by Application (2016-2021)
6.5.2 United States Atezolizumab Revenue Market Share by Application (2016-2021)
6.5.3 United States Atezolizumab Price by Application (2016-2021)
6.6 United States Atezolizumab Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Atezolizumab Sales Forecast by Application (2022-2027)
6.6.2 United States Atezolizumab Revenue Forecast by Application (2022-2027)
6.6.3 United States Atezolizumab Price Forecast by Application (2022-2027)

7 North America
7.1 North America Atezolizumab Market Size YoY Growth 2016-2027
7.2 North America Atezolizumab Market Facts & Figures by Country
7.2.1 North America Atezolizumab Sales by Country (2016-2021)
7.2.2 North America Atezolizumab Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Atezolizumab Market Size YoY Growth 2016-2027
8.2 Asia Pacific Atezolizumab Market Facts & Figures by Region
8.2.1 Asia Pacific Atezolizumab Sales by Region (2016-2021)
8.2.2 Asia Pacific Atezolizumab Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Atezolizumab Market Size YoY Growth 2016-2027
9.2 Europe Atezolizumab Market Facts & Figures by Country
9.2.1 Europe Atezolizumab Sales by Country (2016-2021)
9.2.2 Europe Atezolizumab Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Atezolizumab Market Size YoY Growth 2016-2027
10.2 Latin America Atezolizumab Market Facts & Figures by Country
10.2.1 Latin America Atezolizumab Sales by Country (2016-2021)
10.2.2 Latin America Atezolizumab Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Atezolizumab Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Atezolizumab Market Facts & Figures by Country
11.2.1 Middle East and Africa Atezolizumab Sales by Country (2016-2021)
11.2.2 Middle East and Africa Atezolizumab Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Genentech (Roche)
12.1.1 Genentech (Roche) Corporation Information
12.1.2 Genentech (Roche) Description and Business Overview
12.1.3 Genentech (Roche) Atezolizumab Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Genentech (Roche) Atezolizumab Products Offered
12.1.5 Genentech (Roche) Recent Development
12.11 Genentech (Roche)
12.11.1 Genentech (Roche) Corporation Information
12.11.2 Genentech (Roche) Description and Business Overview
12.11.3 Genentech (Roche) Atezolizumab Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Genentech (Roche) Atezolizumab Products Offered
12.11.5 Genentech (Roche) Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Atezolizumab Industry Trends
13.2 Atezolizumab Market Drivers
13.3 Atezolizumab Market Challenges
13.4 Atezolizumab Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Atezolizumab Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

QYResearch社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68b0f61a4d9868_07068969() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630